Amit V. Khera,Hong-Hee Won,Gina M. Peloso,Colm O'Dushlaine,Dajiang Liu,Nathan O. Stitziel,Pradeep Natarajan,Akihiro Nomura,Connor A. Emdin,Namrata Gupta,Ingrid B. Borecki,Rosanna Asselta,Stefano Duga,Piera Angelica Merlini,Adolfo Correa,Thorsten Kessler,James G. Wilson,Matthew J. Bown,Alistair S. Hall,Peter S. Braund,David J. Carey,Michael F. Murray,H. Lester Kirchner,Joseph B. Leader,Daniel R. Lavage,J. Neil Manus,Dustin N. Hartzel,Nilesh J. Samani,Heribert Schunkert,Jaume Marrugat,Roberto Elosua,Ruth McPherson,Martin Farrall,Hugh Watkins,Eric S. Lander,Daniel J. Rader,John Danesh,Diego Ardissino,Stacey Gabriel,Cristen Willer,Goncalo R. Abecasis,Danish Saleheen,Frederick E. Dewey,Sekar Kathiresan

Abstract:IMPORTANCE The activity of lipoprotein lipase (LPL) is the rate-determining step in clearing triglyceride-rich lipoproteins from the circulation. Mutations that damage the LPL gene (LPL) lead to lifelong deficiency in enzymatic activity and can provide insight into the relationship of LPL to human disease.OBJECTIVE To determine whether rare and/or common variants in LPL are associated with early-onset coronary artery disease (CAD).DESIGN, SETTING, AND PARTICIPANTS In a cross-sectional study, LPL was sequenced in 10 CAD case-control cohorts of the multinational Myocardial Infarction Genetics Consortium and a nested CAD case-control cohort of the Geisinger Health System DiscovEHR cohort between 2010 and 2015. Common variants were genotyped in up to 305 699 individuals of the Global Lipids Genetics Consortium and up to 120 600 individuals of the CARDIoGRAM Exome Consortium between 2012 and 2014. Study-specific estimates were pooled via meta-analysis.EXPOSURES Rare damaging mutations in LPL included loss-of-function variants and missense variants annotated as pathogenic in a human genetics database or predicted to be damaging by computer prediction algorithms trained to identify mutations that impair protein function. Common variants in the LPL gene region included those independently associated with circulating triglyceride levels.MAIN OUTCOMES AND MEASURES Circulating lipid levels and CAD.RESULTS Among 46 891 individuals with LPL gene sequencing data available, the mean (SD) age was 50 (12.6) years and 51% were female. A total of 188 participants (0.40%; 95% CI, 0.35%-0.46%) carried a damaging mutation in LPL, including 105 of 32 646 control participants (0.32%) and 83 of 14 245 participants with early-onset CAD (0.58%). Compared with 46 703 noncarriers, the 188 heterozygous carriers of an LPL damaging mutation displayed higher plasma triglyceride levels (19.6mg/dL; 95% CI, 4.6-34.6mg/dL) and higher odds of CAD (odds ratio = 1.84; 95% CI, 1.35-2.51; P < .001). An analysis of 6 common LPL variants resulted in an odds ratio for CAD of 1.51 (95% CI, 1.39-1.64; P = 1.1 x 10(-22)) per 1-SD increase in triglycerides.CONCLUSIONS AND RELEVANCE The presence of rare damaging mutations in LPL was significantly associated with higher triglyceride levels and presence of coronary artery disease. However, further research is needed to assess whether there are causal mechanisms by which heterozygous lipoprotein lipase deficiency could lead to coronary artery disease.

Association of lipoprotein lipase (LPL) gene variants with hyperlipidemic acute pancreatitis in southeastern Chinese population

Gene polymorphism of lipoprotein lipase in patients with acute hypedipidemic pancreatitis

Compound but Non-Linked Heterozygous P.w14x and P.l279 V LPL Gene Mutations in a Chinese Patient with Long-Term Severe Hypertriglyceridemia and Recurrent Acute Pancreatitis.

Identification of a Novel LPL Nonsense Variant and Further Insights into the Complex Etiology and Expression of Hypertriglyceridemia-Induced Acute Pancreatitis

Identification and functional characterization of mutations in LPL gene causing severe hypertriglyceridaemia and acute pancreatitis.

Sequencing of Lipoprotein Lipase Gene in 11 Cases of Chinese Patients with Severe Endogenous Hypertriglyceridemia.

Single-nucleotide Polymorphisms in the Lipoprotein Lipase Gene Associated with Coronary Heart Disease in Chinese

A Novel Lipoprotein Lipase Gene Missense Mutation in Chinese Patients with Severe Hypertriglyceridemia and Pancreatitis

Identification and Functional Characterization of a Novel Heterozygous Missense Variant in the LPL Associated with Recurrent Hypertriglyceridemia‐induced Acute Pancreatitis in Pregnancy

Linkage and Linkage Disequilibrium Analysis of the Lipoprotein Lipase Gene with Lipid Profiles in Chinese Hypertensive Families.

Significant but partial lipoprotein lipase functional loss caused by a novel occurrence of rare LPL biallelic variants

Exploring the enigmatic association between PNLIP variants and risk of chronic pancreatitis in a large Chinese cohort

Association of endothelial lipase gene Thr111Ile and Gly26Ser polymorphism with lipoprotein in patients with coronary heart disease

Linkage and linkage disequilibrium analysis of the lipoprotein lipase gene with lipid profiles in Chinese hypertensive families

E0103 the HindIII Polymorphism in the Lipoprotein Lipase Gene Predicts Type 2 Diabetes Risk among Chinese Adults

Relationship Between A Novel Polymorphism of Lipoprotein Lipase Gene and Coronary Heart Disease

Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease

Study on LPL Gene Mutations

Association of Rare and Common Variation in the Lipoprotein Lipase Gene with Coronary Artery Disease

A Phenome-Wide Association Study of A Lipoprotein-Associated Phospholipase A(2) Loss-Of-Function Variant in 90 000 Chinese Adults

Associations Between LPL Gene Polymorphisms and Coronary Artery Disease: Evidence Based on an Updated and Cumulative Meta-Analysis.